Literature DB >> 23408348

Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study.

Hashem B El-Serag1, Ali Hashmi, Jose Garcia, Peter Richardson, Abeer Alsarraj, Stephanie Fitzgerald, Marcelo Vela, Yasser Shaib, Neena S Abraham, Maria Velez, Rhonda Cole, Margot B Rodriguez, Bhupinderjit Anand, David Y Graham, Jennifer R Kramer.   

Abstract

OBJECTIVE: Abdominal obesity has been associated with increased risk of Barrett's oesophagus (BE) but the underlying mechanism is unclear. We examined the association between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) and the risk of BE.
DESIGN: A case-control study among eligible patients scheduled for elective oesophagastroduodenoscopy (EGD) and in a sample of patients eligible for screening colonoscopy recruited at the primary care clinic. All cases with definitive BE and a random sample of controls without BE were invited to undergo standardised mid-abdomen non-contrast computerised axial tomography images, which were analysed by semiautomated image segmentation software. The effect of VAT and SAT surface areas and their ratio (VAT to SAT) on BE were analysed in logistic regression models.
RESULTS: A total of 173 BE cases, 343 colonoscopy controls and 172 endoscopy controls underwent study EGD and CT scan. Participants with BE were more than twice as likely to be in the highest tertile of VAT to SAT ratio (OR: 2.42 (1.51 to 3.88) and adjusted OR 1.47 (0.88 to 2.45)) than colonoscopy controls, especially for those long (≥3 cm) segment BE (3.42 (1.67 to 7.01) and adjusted OR 1.93 (0.92 to 4.09)) and for white men (adjusted OR 2.12 (1.15 to 3.90)). Adjustment for gastroesophageal reflux disease (GERD) symptoms and proton pump inhibitors (PPI) use attenuated this association, but there was a significant increase in BE risk even in the absence of GERD or PPI use.
CONCLUSIONS: Large amount of visceral abdominal fat relative to subcutaneous fat is associated with a significant increase in the risk of BE. GERD may mediate some but not all of this association.

Entities:  

Keywords:  Epidemiology; Obesity

Mesh:

Year:  2013        PMID: 23408348      PMCID: PMC3976427          DOI: 10.1136/gutjnl-2012-304189

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging.

Authors:  Marilyn J Siegel; Charles F Hildebolt; Kyongtae T Bae; Cheng Hong; Neil H White
Journal:  Radiology       Date:  2007-01-23       Impact factor: 11.105

Review 2.  A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus.

Authors:  Michael B Cook; Darren C Greenwood; Laura J Hardie; Christopher P Wild; David Forman
Journal:  Am J Gastroenterol       Date:  2007-11-06       Impact factor: 10.864

3.  Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging.

Authors:  S Bonekamp; P Ghosh; S Crawford; S F Solga; A Horska; F L Brancati; A M Diehl; S Smith; J M Clark
Journal:  Int J Obes (Lond)       Date:  2007-08-14       Impact factor: 5.095

4.  Central adiposity and risk of Barrett's esophagus.

Authors:  Zoe R Edelstein; Diana C Farrow; Mary P Bronner; Sheldon N Rosen; Thomas L Vaughan
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

5.  Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms.

Authors:  Douglas A Corley; Ai Kubo; Wei Zhao
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

6.  Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.

Authors:  Shubha Srinivasan; Geoffrey R Ambler; Louise A Baur; Sarah P Garnett; Mirijana Tepsa; Fabian Yap; Glenn M Ward; Christopher T Cowell
Journal:  J Clin Endocrinol Metab       Date:  2006-04-04       Impact factor: 5.958

Review 7.  Inflammation, obesity, and the metabolic syndrome.

Authors:  J S Yudkin
Journal:  Horm Metab Res       Date:  2007-10       Impact factor: 2.936

Review 8.  When and how to grade Barrett's columnar metaplasia: the Prague system.

Authors:  Oksana Anand; Sachin Wani; Prateek Sharma
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

Review 9.  Role of obesity in GORD-related disorders.

Authors:  Hashem El-Serag
Journal:  Gut       Date:  2008-03       Impact factor: 23.059

10.  Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.

Authors:  Juraj Koska; Norbert Stefan; Paska A Permana; Christian Weyer; Mina Sonoda; Clifton Bogardus; Steven R Smith; Denis R Joanisse; Tohru Funahashi; Jonathan Krakoff; Joy C Bunt
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

View more
  49 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

3.  Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.

Authors:  Jose M Garcia; Andres E Splenser; Jennifer Kramer; Abeer Alsarraj; Stephanie Fitzgerald; David Ramsey; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

Review 4.  Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.

Authors:  Craig S Brown; Michael B Ujiki
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

Review 5.  Obesity and GERD.

Authors:  Paul Chang; Frank Friedenberg
Journal:  Gastroenterol Clin North Am       Date:  2013-12-27       Impact factor: 3.806

Review 6.  Barrett's oesophagus: frequency and prediction of dysplasia and cancer.

Authors:  Gary W Falk
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-01-20       Impact factor: 3.043

7.  Association of sporadic and familial Barrett's esophagus with breast cancer.

Authors:  M Q Chan; A E Blum; A K Chandar; A M L Kieber Emmons; Y Shindo; W Brock; G W Falk; M I Canto; J S Wang; P G Iyer; N J Shaheen; W M Grady; J A Abrams; P N Thota; K K Guda; A Chak
Journal:  Dis Esophagus       Date:  2018-04-01       Impact factor: 3.429

8.  The Outcomes of Laparoscopic Biliopancreatic Diversion with Duodenal Switch on Gastro-esophageal Reflux Disease: the Mayo Clinic Experience.

Authors:  Joseph N Badaoui; Todd A Kellogg; Barham K Abu Dayyeh; Justin W Maroun; Travis J McKenzie; William S Harmsen; Michael L Kendrick; Omar M Ghanem
Journal:  Obes Surg       Date:  2021-07-22       Impact factor: 4.129

Review 9.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

10.  A multibiomarker risk score helps predict risk for Barrett's esophagus.

Authors:  Aaron P Thrift; Jose M Garcia; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-19       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.